Nippon Pharmaceuticuals (India) Private Limited - Company Profile

It is a healthcare private limited company based in Chennai, Tamil Nadu, India, established in 1980.
1980 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Nippon Pharmaceuticuals (India) Private Limited

Nippon Pharmaceuticuals (India) Private Limited, a active private limited company, was established on 14 February 1980 in Chennai, Tamil Nadu, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24230TN1980PTC008130. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.88 M.

It upholds a compliant status. Its leadership includes Vijay Anand (Additional Director), Mahalakshmi (Additional Director). Past directors included Suhasini Azariah Hemandranath Azariah, Hemandranath Azariah, Gitanjali Azariah. It holds ₹20.00 K open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Door No.18/2,Ground Floor,2Nd Street, Parvathipuram, Thiruneermalai Main Road,, Chromepet, Chennai, Tamil Nadu, 600044.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TN1980PTC008130

  • Registration Number

    008130

  • Incorporation Date

    14 February 1980

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.88 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.88 M
  • Company Age 46 Year, 1 Month
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 20.00 K
  • Revenue Growth **** -28.29%
  • Profit Growth **** -12.81%
  • Ebitda **** -12.81%
  • Net Worth -25.85%
  • Total Assets -25.34%
Company report

Nippon Pharmaceuticuals (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nippon Pharmaceuticuals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nippon Pharmaceuticuals (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Vijay Anand Additional Director 11 Apr 2022 Current
Mahalakshmi Additional Director 11 Apr 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 11 Apr 2022 Past
Pramod Abcsdd Director 11 Apr 2022 Past
Pramod Abcsdd Director 11 Apr 2022 Past
Pramod Abcsdd Director 20 Aug 2018 Past
Pramod Abcsdd Director 17 Oct 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nippon Pharmaceuticuals (India).

Nippon Pharmaceuticuals (India) Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 28.29% decrease. The company also saw a substantial fall in profitability, with a 12.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.85%.

Nippon Pharmaceuticuals (India) revenue growth over time
Nippon Pharmaceuticuals (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -28.29%
*******
*******
*******
*******
Revenue from Operations
*******
 -28.29%
*******
*******
*******
*******
Total Assets
*******
 -25.34%
*******
*******
*******
*******
Profit or Loss
*******
 -12.81%
*******
*******
*******
*******
Net Worth
*******
 -25.85%
*******
*******
*******
*******
EBITDA
*******
 -12.81%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nippon Pharmaceuticuals (India)?

In 2021, Nippon Pharmaceuticuals (India) had a promoter holding of 55.52% and a public holding of 44.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹20,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Indian Bank : 0.00 Cr
Latest Charge Details
Date Lender Amount Status
21 Aug 1986 Indian Bank ₹0.02 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Nippon Pharmaceuticuals (India)?

Unlock and access historical data on people associated with Nippon Pharmaceuticuals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nippon Pharmaceuticuals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nippon Pharmaceuticuals (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nippon Pharmaceuticuals (India)
Recent Activity within the Organization
  • Director Appointment

    Vijay Anand was appointed as a Additional Director was appointed as a Additional Director on 11 Apr 2022 & has been associated with this company since 3 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Mahalakshmi was appointed as a Additional Director was appointed as a Additional Director on 11 Apr 2022 & has been associated with this company since 3 years 11 months . was completed.

  • Annual General Meeting

    The activity Nippon Pharmaceuticuals (India) Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Nippon Pharmaceuticuals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Chennai. was documented.

  • Charges

    The activity A charge with Indian Bank amounted to Rs. 0.02 M with Charge ID 90307002 was registered on 21 Aug 1986. was completed.

  • Company Incorporation

    Progress on Nippon Pharmaceuticuals (India) Private Limited was registered on 14 Feb 1980 with Roc Chennai & aged 46 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nippon Pharmaceuticuals (India) Private Limited?

The CIN of Nippon Pharmaceuticuals (India) Private Limited is U24230TN1980PTC008130.

Where is Nippon Pharmaceuticuals (India) Private Limited headquartered?

Nippon Pharmaceuticuals (India) Private Limited is headquartered at Door No.18/2,Ground Floor,2Nd Street, Parvathipuram, Thiruneermalai Main Road,, Chromepet, Chennai, Tamil Nadu, 600044.

When was Nippon Pharmaceuticuals (India) Private Limited incorporated?

Nippon Pharmaceuticuals (India) Private Limited was incorporated on 14 February 1980.

Who are the current directors of Nippon Pharmaceuticuals (India) Private Limited?

The current directors of Nippon Pharmaceuticuals (India) Private Limited are

What is the primary industry of Nippon Pharmaceuticuals (India) Private Limited?

The primary industry of Nippon Pharmaceuticuals (India) Private Limited is Manufacturing.

Is Nippon Pharmaceuticuals (India) Private Limited a listed company?

Nippon Pharmaceuticuals (India) Private Limited is unlisted.

What is the capital structure of Nippon Pharmaceuticuals (India) Private Limited?

The authorized capital of Nippon Pharmaceuticuals (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.88 M.

What is the compliance status of Nippon Pharmaceuticuals (India) Private Limited?

The compliance status of Nippon Pharmaceuticuals (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available